Yamaguchi University   Report issue

Academic/Hospital Phase 1 Phase 4
Founded: Yamaguchi Japan (1894)

Organization Overview

First Clinical Trial
2003
NCT00135551
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine | Professor of Medicine, Department of Cardiovascular Medicine, Yamaguchi University Graduate School of Medicine | Yamaguchi University Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Cardiovascular Diseases (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Heart Diseases (Phase 4)

Hemorrhage (Phase 4)

Hypercholesterolemia (Phase 4)

Myocardial Ischemia (Phase 4)

Subarachnoid Hemorrhage (Phase 4)

Vasospasm, Intracranial (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 8